Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
JCTCF
|
Community Foundation Oregon
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,487 Reduced 0.18% |
$3,375
$2.27 p/Share
|
Jan 02
2026 |
|
JANX
|
Maria Dobek
Vice President, Accounting |
SELL
Open market or private sale
|
Direct | 1,462 Reduced 8.68% |
$20,073
$13.73 p/Share
|
Jan 02
2026 |
|
JANX
|
Zachariah Mc Iver
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,714 Reduced 10.44% |
$37,263
$13.73 p/Share
|
Jan 02
2026 |
|
JANX
|
Charles M. Winter
Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 2,401 Reduced 3.0% |
$32,965
$13.73 p/Share
|
Jan 02
2026 |
|
JANX
|
David Alan Campbell
President and CEO |
SELL
Open market or private sale
|
Direct | 8,072 Reduced 2.75% |
$110,828
$13.73 p/Share
|
Jan 02
2026 |
|
JANX
|
Thomas Di Raimondo
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,505 Reduced 1.97% |
$34,393
$13.73 p/Share
|
Jan 02
2026 |
|
JANX
|
Andrew Hollman Meyer
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 1,879 Reduced 2.21% |
$25,798
$13.73 p/Share
|
Jan 02
2026 |
|
AVAH
|
Patrick A. Cunningham
Chief Compliance Officer |
SELL
Open market or private sale
|
Direct | 12,445 Reduced 4.07% |
$97,693
$7.85 p/Share
|
Jan 02
2026 |
|
AVAH
|
Deborah Stewart
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 11,962 Reduced 4.54% |
$93,901
$7.85 p/Share
|
Jan 02
2026 |
|
AVAH
|
Jeff Shaner
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 29,357 Reduced 1.21% |
$230,452
$7.85 p/Share
|
Jan 02
2026 |
|
AVAH
|
Edwin C. Reisz
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 17,613 Reduced 1.32% |
$138,262
$7.85 p/Share
|
Jan 02
2026 |
|
ABIO
|
Laura Lee Sandler
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 5.96% |
$377,000
$29.0 p/Share
|
Jan 02
2026 |
|
AVAH
|
Matthew Buckhalter
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 18,340 Reduced 4.03% |
$143,969
$7.85 p/Share
|
Jan 02
2026 |
|
XENE
|
Ian Mortimer
PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 86.96% |
$1,786,800
$44.67 p/Share
|
Jan 02
2026 |
|
ZS
|
James A Beer
Director |
SELL
Open market or private sale
|
Direct | 653 Reduced 15.78% |
$148,048
$226.72 p/Share
|
Jan 02
2026 |
|
CYTK
|
Andrew Callos
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 1,798 Reduced 3.44% |
$112,608
$62.63 p/Share
|
Jan 02
2026 |
|
MAX
|
Kuanling Amy Yeh
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 0.75% |
$38,850
$12.95 p/Share
|
Jan 02
2026 |
|
OMF
|
Douglas H. Shulman
President & CEO |
SELL
Open market or private sale
|
Direct | 57,500 Reduced 24.83% |
$3,934,150
$68.42 p/Share
|
Jan 02
2026 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 18,568 Reduced 0.0% |
$11,697
$0.63 p/Share
|
Jan 02
2026 |
|
CLNN
|
Chidozie Ugwumba
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,015 Reduced 0.0% |
$23,005
$5.73 p/Share
|
Jan 02
2026 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 632,874 Reduced 0.0% |
$2,797,303
$4.42 p/Share
|
Jan 02
2026 |
|
CPNG
|
Jonathan D. Lee
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,679 Reduced 2.15% |
$63,277
$23.62 p/Share
|
Jan 02
2026 |
|
CURI
|
Phillip Brady Hayden
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 17,474 Reduced 0.0% |
$65,702
$3.76 p/Share
|
Jan 02
2026 |
|
CNO
|
Gary C Bhojwani
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 31,430 Reduced 13.82% |
$1,319,745
$41.99 p/Share
|
Jan 02
2026 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$737,100
$16.38 p/Share
|
Jan 02
2026 |
|
ALKS
|
Craig C. Hopkinson
EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 6.08% |
$112,000
$28.0 p/Share
|
Jan 02
2026 |
|
UTHR
|
Paul A Mahon
EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 8,300 Reduced 18.41% |
$4,025,915
$485.05 p/Share
|
Jan 02
2026 |
|
YELP
|
Craig Saldanha
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 0.62% |
$36,516
$30.43 p/Share
|
Jan 02
2026 |
|
LUCY
|
Vladimir Galkin |
SELL
Open market or private purchase
|
Direct | 1,262 Reduced 0.19% |
$1,224
$0.97 p/Share
|
Jan 02
2026 |
|
AKAM
|
Adam Karon
COO & GM Edge Technology Group |
SELL
Open market or private sale
|
Direct | 3,320 Reduced 29.9% |
$289,836
$87.3 p/Share
|
Jan 02
2026 |
|
JCTCF
|
Community Foundation Oregon
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,519 Reduced 0.3% |
$5,718
$2.27 p/Share
|
Dec 31
2025 |
|
CRWV
|
Michael N Intrator
CEO and President |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 0.0% |
$3,594,000
$71.88 p/Share
|
Dec 31
2025 |
|
CRWV
|
Michael N Intrator
CEO and President |
SELL
Open market or private sale
|
Direct | 111,427 Reduced 1.85% |
$8,046,143
$72.21 p/Share
|
Dec 31
2025 |
|
CRWV
|
Brannin Mc Bee
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 57,636 Reduced 18.82% |
$4,190,137
$72.7 p/Share
|
Dec 31
2025 |
|
CRWV
|
Brian M Venturo
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 65,940 Reduced 19.28% |
$4,796,475
$72.74 p/Share
|
Dec 31
2025 |
|
AVAH
|
Patrick A. Cunningham
Chief Compliance Officer |
SELL
Open market or private sale
|
Direct | 11,731 Reduced 3.69% |
$95,959
$8.18 p/Share
|
Dec 31
2025 |
|
AVAH
|
Deborah Stewart
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 11,275 Reduced 4.1% |
$92,229
$8.18 p/Share
|
Dec 31
2025 |
|
AVAH
|
Jeff Shaner
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,674 Reduced 1.13% |
$226,373
$8.18 p/Share
|
Dec 31
2025 |
|
AVAH
|
Edwin C. Reisz
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 16,602 Reduced 1.22% |
$135,804
$8.18 p/Share
|
Dec 31
2025 |
|
AVAH
|
Matthew Buckhalter
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 17,289 Reduced 3.66% |
$141,424
$8.18 p/Share
|
Dec 31
2025 |
|
MEGI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 12,500 Reduced 0.0% |
$172,875
$13.83 p/Share
|
Dec 31
2025 |
|
AXSM
|
Mark E Saad |
SELL
Open market or private sale
|
Direct | 37,577 Reduced 78.98% |
$6,206,968
$165.18 p/Share
|
Dec 31
2025 |
|
AI
|
Stephen Bradley Ehikian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 234,918 Reduced 20.27% |
$3,185,488
$13.56 p/Share
|
Dec 31
2025 |
|
ARQT
|
Patrick Burnett
Officer |
SELL
Open market or private sale
|
Direct | 1,697 Reduced 1.73% |
$49,382
$29.1 p/Share
|
Dec 31
2025 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 24,962 Reduced 0.0% |
$15,476
$0.62 p/Share
|
Dec 31
2025 |
|
VRDN
|
Jennifer Tousignant
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,272 Reduced 100.0% |
$70,795
$31.16 p/Share
|
Dec 31
2025 |
|
CLNN
|
Chidozie Ugwumba
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,095 Reduced 0.0% |
$76,081
$5.81 p/Share
|
Dec 31
2025 |
|
BXMT
|
Fernando Austin Pena
President |
SELL
Open market or private sale
|
Direct | 3,131 Reduced 3.83% |
$60,240
$19.24 p/Share
|
Dec 31
2025 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 632,874 Reduced 0.0% |
$2,765,659
$4.37 p/Share
|
Dec 31
2025 |
|
AUUD
|
Jeffrey John Thramann
CEO and Executive Chairman |
SELL
Open market or private sale
|
Direct | 2,301 Reduced 49.41% |
$2,208
$0.96 p/Share
|
Dec 31
2025 |